Back to Top Skip to main content Skip to sub-navigation

Senior Medical Leaders Discuss COVID-19 Response

Army Lt. Gen. (Dr.) Ronald J. Place, director of the Defense Health Agency making remarks Army Lt. Gen. (Dr.) Ronald J. Place, director of the Defense Health Agency, makes remarks during a panel discussion on the COVID-19 Emergency Response and Post-Pandemic National Security at the Sea-Air-Space Conference and Exposition at Gaylord National Resort and Convention Center in National Harbor, Maryland, August 4 (Photo by: Jacob Moore, MHS Communications).

Recommended Content:

COVID-19 Vaccine Toolkit | Coronavirus

At the beginning, the key to tackling the emerging COVID-19 pandemic was to quickly develop a comprehensive understanding of the virus, and then put a plan in place to fight it, explained Army Lt. Gen. (Dr.) Ronald J. Place, director of the Defense Health Agency.

Place's remarks came during a panel discussion on the COVID-19 response and post-pandemic national security at the Sea-Air-Space Conference and Exposition at Gaylord National Resort and Convention Center at National Harbor in Maryland, August 4.

The panel was moderated by Dr. Eric Thompson, vice president and director of strategy, policy, plans and programs for the Center for Naval Analysis, and included Place, Navy Surgeon General Rear Adm. (Dr.) Bruce Gillingham and Coast Guard Rear Adm. (Dr.) Dana Thomas, director of health, safety and work-life for the Coast Guard.

Early in the pandemic, Place said, the mission of military and public health officials was, first and foremost, to understand how to frame the problem.

"What is it? How do you diagnose it? How is it transmitted? How can you protect yourself from it? How can you treat it? What are the right diagnostic tools?" were some of the questions asked in early 2020,Place said.

Another concern Place shared was whether the Department of Defense had the correct systems in place to combat the disease, either at individual locations or throughout the department.

Quick action and early understanding of the virus drove the number of DOD laboratories that were able to test for COVID-19 from 11 in February 2020 to approximately 177 currently.

The integrated nature of the Military Health System pre-pandemic greatly assisted in DOD's readiness, Place said.

"We have a system in place that knows how to [integrate care]. We have a system in place that knows how to talk to each other. We have a system that has a centralized logistics arm, a centralized pharmacy arm. We already had on-the-shelf pandemic plans," said Place.

While perhaps not perfect or designed for a pandemic on the scale of the COVID-19 pandemic these pre-existing plans helped position the DOD to respond.

Military personnel on a panel
A panel on the COVID-19 Emergency Response and Post-Pandemic National Security hosted by Dr. Eric Thompson, vice president and director of strategy, policy, plans and programs for the Center for Naval Analysis, and consisting of Army Lt. Gen. (Dr.) Ronald J. Place, director of the Defense Health Agency, Navy Surgeon General Rear Adm. (Dr.) Bruce Gillingham and Coast Guard Rear Adm. (Dr.) Dana Thomas, director of health, safety and work-life for the Coast Guard, speaks to audience members at the Sea-Air-Space Conference and Exposition at Gaylord National Resort and Convention Center in National Harbor, Maryland, August 4 (Photo by: Jacob Moore, MHS Communications).

Gillingham added that these plans extended to working with other agencies, such as the Federal Emergency Management Agency, to support the civilian pandemic response outside of the DOD.

"To General Place's point, the framework was there. The way that we were set up within the Military Health System lent itself (to the response)," said Gillingham. "Early on, we established a really good battle rhythm of interagency coordination."

He also commended Place and the DHA for their coordination of vaccine distribution.

"Hats off to General Place and his team at the Defense Health Agency for providing the central coordination, and establishing and leading the OPT, the Operational Planning Team to say, "how are we going to distribute the vaccine?" and then working through the services to execute," said Gillingham. "That really is a very effective model that I think we can leverage into the future."

Gillingham said that he is continuing to push his sailors to get vaccinated and, for him, getting vaccinated is a "game changer."

"We continue to push for our force to get vaccinated. It's a readiness issue for us, first and foremost. If you're vaccinated, you're much less likely to get very ill or be hospitalized, so you're going to be in the game," said Gillingham.

We would not send our folks into combat without flak and Kevlar. The enemy, this time, is a virus and we have a biological body armor for them to take and use to protect themselves," he added.

Place also took the opportunity to remind those in attendance that the battle against COVID-19 is not over.

"I think one of the things that many of us believe - which is a fallacy - is that [COVID-19] is going to go away. It's not going away, just like influenza is not going away. And the thing about many viruses is they tend to mutate, and they tend to do things that keep them alive."

He noted, however, that the DOD medical team has an "insatiable curiosity," and that medical research within the department is in a continuous process of improvement.

The full discussion can be found here.

You also may be interested in...

DHA-PI 6205.01: Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (n), establishes the Defense Health Agency's (DHA's) procedures for ordering, receiving, and managing COVID-19 Vaccines inventory and ancillary kits.

DHA-IPM 20-004: Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

Policy

This Defense Health Agency (DHA) Interim Procedures Memorandum (IPM), based on the authority of References (a) through (d), and in accordance with the guidance cited in References (e) through (aa), establishes the DHA’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the COVID-19 Vaccination Program. This DHA-IPM applies to DHA, DHA Components (activities under the authority direction, and control of the DHA), Military Departments (MILDEP), and the United States Coast Guard (CG). This DHA-IPM cancels and replaces DHA-IPM 20-004, “Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation,” December 13, 2020.

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

  • Identification #: N/A
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

  • Identification #: 20-003
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

Supplemental Guidance for Providing DoD Coronavirus Disease 2019 Vaccines to DoD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DoD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components.

DHA-AI 3020-01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), based on the authority of References (a) through (b) and in accordance with the guidance of References (c) through (z3), establishes the Defense Health Agency's (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic. This DHA-AI also provides a preventive plan to monitor and assess for the appearance of new cases and implement those processes that will prevent them from impacting the workforce. The processes describe herein are intended to offer an actionable plan for the workforce to re-enter DHA Administrative Offices. See Appendix 1 for a summary of the DHA Administrative Office Reopening Plan. The plan uses the Force Health Protection Guidance and Health Protection Conditions (HPCON), in accordance with Reference (d), to ensure protection for the workforce, including the most vulnerable-to-serious complications from the virus while enabling DHA Administrative Offices to continue its mission. See Appendix 2 for the conceptual HPCON framework.

  • Identification #: 3020-01
  • Date: 11/3/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

DHA-AI 3020.01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 (COVID-19) Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), establishes the Defense Health Agency’s (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic and in preparation for regression or resurgence in COVID-19 cases that could impact the workforce.

  • Identification #: 3020.01
  • Date: 6/12/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

Policy

The Defense Health Agency (DHA) Memorandum, based on the authority of References (a) and (b), and in accordance with the guidance of References (c) and (d), establishes the DHA’s procedures to standardize the coding for Coronavirus 2019 (COVID-19) Military Medical Treatment Facilities (MTFs). This memorandum cancels and replaces DHA- Policy Memorandum 20-003 of (13 April 2020). A change was issued since the cancelled Memorandum 20-003 of (13 April 2020), the Attachment titles were updated to reflect that Attachments 1, 2, and 4 are considered Policies as opposed to Guidance.

  • Identification #: 20-003
  • Date: 5/13/2020
  • Type: Memorandums
  • Topics: Coronavirus
Showing results 1 - 11 Page 1 of 1

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.